Genetic polymorphisms in sepsis- and cardiopulmonary bypass-associated acute kidney injury

Contributions to Nephrology

Volumn 156, Issue , 2007, Pages 75-91

  Haase Fielitz, Anja ^a,b   Haase, Michael ^a,b   Bellomo, Rinaldo ^a,d   Dragun, Duska ^c  

^a AUSTIN HEALTH   (Australia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; CARDIOPULMONARY BYPASS; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; HUMAN; REVIEW; RISK FACTOR; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEINS E; CARDIOPULMONARY BYPASS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY FAILURE, ACUTE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247604176     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102072     Document Type: Review

References (85)

1. Hou SH, Bushinsky DA, Wish JB, et al: Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-248.
2. Uchino S, Kellum JA, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-818.
3. Uchino S, Bellomo R, Goldsmith D, et al: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006;34:1913-1917.
4. Chertow GM, Levy EM, Hammermeister KE, et al: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-348.
5. De Mendonca A, Vincent JL, Suter PM, et al: Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000;26:915-921.
6. Zanardo G, Michielon P, Paccagnella A, et al: Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994;107: 1489-1495.
7. Chertow GM, Lazarus JM, Christiansen CL, et al: Preoperative renal risk stratification. Circulation 1997;95:878-884.
8. Ford EB: Genetic polymorphism. Proc R Soc Lond B Biol Sci 1966;164:350-361.
9. Hsu TC, Klatt O: Mammalian chromosomes in vitro. IX. On genetic polymorphism in cell populations. J Natl Cancer Inst 1958;21:437-473.
10. Klenzak J, Himmelfarb J: Sepsis and the kidney. Crit Care Clin 2005;21:211-222.
11. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123.
12. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
13. Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 2001;29(suppl):S99-S106.
14. Wan L, Bellomo R, Di Giantomasso D, et al: The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003;9:496-502.
15. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-1477.
16. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997;112:235-243.
17. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993;103:565-575.
18. Hack CE, Aarden LA, Thijs LG: Role of cytokines in sepsis. Adv Immunol 1997;66:101-195.
19. Messmer UK, Briner VA, Pfeilschifter J: Basic fibroblast growth factor selectively enhances TNFalpha-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol 2000;11:2199-2211.
20. Lieberthal W, Triaca V, Levine J: Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996;270:F700-F708.
21. Kohan DE: Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 1994;9(suppl 4):73-77.
22. Karnik AM, Bashir R, Khan FA, et al: Renal involvement in the systemic inflammatory reaction syndrome. Ren Fail 1998;20:103-116.
23. Knotek M, Rogachev B, Wang W, et al: Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001;59:2243-2249.
24. Jaber BL, Pereira BJ, Bonventre JV, et al: Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. Kidney Int 2005;67:14-33.
25. Dollner H, Vatten L, Linnebo I, et al: Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate 2001;80:41-47.
26. Treszl A, Toth-Heyn P, Kocsis I, et al: Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 2002;17:713-717.
27. Vincent JL, de Mendonca A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-1800.
28. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
29. Gordon AC, Lagan AL, Aganna E, et al: TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 2004;5:631-640.
30. Sibbald WJ, Vincent JL: Round table conference on clinical trials for the treatment of sepsis. Brussels, March 12-14, 1994. Intensive Care Med 1995;21:184-189.
31. Wattanathum A, Manocha S, Groshaus H, et al: Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 2005;128:1690-1698.
32. Perianayagam MC, Liangos O, Kolyada AY, et al: NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007;18:255-263.
33. Reinhart K, Menges T, Gardlund B, et al: Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med 2001;29:765-769.
34. Gallagher J, Fisher C, Sherman B, et al: A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-alpha antibody afelimomab in patients with sepsis syndrome. Intensive Care Med 2001;27:1169-1178.
35. Baud L, Oudinet JP, Bens M, et al: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989;35:1111-1118.
36. Pinsky MR: The critically ill patient. Kidney Int Suppl 1998;66:S3-S6.
37. Camussi G, Ronco C, Montrucchio G, et al: Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 1998;66:S38-S42.
38. Wilson AG, de Vries N, Pociot F, et al: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-560.
39. Morse HR, Olomolaiye OO, Wood NA, et al: Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine 1999;11:789-795.
40. Warzocha K, Ribeiro P, Bienvenu J, et al: Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998;91:3574-3581.
41. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-172.
42. Jaber BL, Pereira BJ: Extracorporeal adsorbent-based strategies in sepsis. Am J Kidney Dis 1997;30(suppl 4):S44-S56.
43. Jaber BL, Rao M, Guo D, et al: Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004;25:212-219.
44. Fekete A, Treszl A, Toth-Heyn P, et al: Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 2003;54:452-455.
45. Stallwood MI, Grayson AD, Mills K, et al: Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg 2004;77:968-972.
46. Wijeysundera DN, Rao V, Beattie WS, et al: Evaluating surrogate measures of renal dysfunction after cardiac surgery. Anesth Analg 2003;96:1265-1273.
47. Lassnigg A, Schmidlin D, Mouhieddine M, et al: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-1605.
48. Stafford-Smith M, Podgoreanu M, Swaminathan M, et al: Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005;45:519-530.
49. Mangano CM, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
50. Conlon PJ, Stafford-Smith M, White WD, et al: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999;14:1158-1162.
51. Thakar CV, Arrigain S, Worley S, et al: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005;16:162-168.
52. Starkopf J, Zilmer K, Vihalemm T, et al: Time course of oxidative stress during open-heart surgery. Scand J Thorac Cardiovasc Surg 1995;29:181-186.
53. McColl AJ, Keeble T, Hadjinikolaou L, et al: Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 1998;35:616-623.
54. Doi K, Suzuki Y, Nakao A, et al: Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 2004;65:1714-1723.
55. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
56. Andersson LG, Bratteby LE, Ekroth R, et al: Renal function during cardiopulmonary bypass: influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 1994;8:597-602.
57. Abbott WM, Austen WG: The reversal of renal cortical ischemia during aortic occlusion by mannitol. J Surg Res 1974;16:482-489.
58. Dada LA, Chandel NS, Ridge KM, et al: Hypoxia-induced endocytosis of Na/K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest 2003;111:1057-1064.
59. Chello M, Mastroroberto P, Patti G, et al: Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 2003;89:538-543.
60. Boyle EM Jr, Lille ST, Allaire E, et al: Endothelial cell injury in cardiovascular surgery: atherosclerosis. Ann Thorac Surg 1997;63:885-894.
61. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-244.
62. Partrick DA, Moore EE, Fullerton DA, et al: Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 1999;86:42-49.
63. Strittmatter WJ, Saunders AM, Schmechel D, et al: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
64. Eichner JE, Kuller LH, Orchard TJ, et al: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993;71:160-165.
65. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
66. Corder EH, Saunders AM, Risch NJ, et al: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.
67. Tardiff BE, Newman MF, Saunders AM, et al: Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 1997;64:715-720.
68. Nath KA, Norby SM: Reactive oxygen species and acute renal failure. Am J Med 2000;109:665-678.
69. Cunningham PN, Dyanov HM, Park P, et al: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002;168:5817-5823.
70. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000;11:152-176.
71. Heyman SN, Rosen S, Darmon D, et al: Endotoxin-induced renal failure. II. A role for tubular hypoxic damage. Exp Nephrol 2000;8:275-282.
72. Macarthur H, Westfall TC, Riley DP, et al: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 2000;97:9753-9758.
73. Bindoli A, Rigobello MP, Deeble DJ: Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 1992;13:391-405.
74. Stokes AH, Hastings TG, Vrana KE: Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 1999;55:659-665.
75. Bolton JL, Trush MA, Penning TM, et al: Role of quinones in toxicology. Chem Res Toxicol 2000;13:135-160.
76. Gaudino M, Di Castelnuovo A, Zamparelli R, et al: Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery. J Thorac Cardiovasc Surg 2003;126:1107-1112.
77. Fishman D, Faulds G, Jeffery R, et al: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
78. Ferrari SL, Ahn-Luong L, Garnero P, et al: Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003;88:255-259.
79. Chew ST, Newman MF, White WD, et al: Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 2000;93:325-331.
80. MacKensen GB, Swaminathan M, Ti LK, et al: Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg 2004;78:520-526.
81. Weinshilboum RM, Raymond FA: Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet 1977;29:125-135.
82. Floderus Y, Wetterberg L: The inheritance of human erythrocyte catechol-O-methyltransferase activity. Clin Genet 1981;19:392-395.
83. Axelrod J, Tomchick R: Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958;233:702-705.
84. Kalfin RE, Engelman RM, Rousou JA, et al: Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 1993;88:II401-II406.
85. Schmid FX, Vudattu N, Floerchinger B, et al: Endothelial apoptosis and circulating endothelial cells after bypass grafting with and without cardiopulmonary bypass. Eur J Cardiothorac Surg 2006;29:496-500.